retatrutide clinical data Retatrutide—A Game Changer in Obesity Pharmacotherapy New Phase 3 retatrutide data

One way the gut microbiome impacts our well-being is by producing GLP-1

Patients should be wary of prices that seem too good to be true, as this often indicates a counterfeit product made with cheap, unknown ingredients

Starting the conversation with a clinician about what happens next before the first injection is an important part of an informed decision

Possible concerns may include nausea, vomiting, diarrhea, constipation, appetite suppression, dehydration, fatigue, gallbladder concerns, blood sugar changes, excessive weight loss, and loss of lean muscle if weight drops too quickly

Sign Up Quick Summary Retatrutide is an investigational triple-hormone receptor agonist that targets GLP-1, GIP, and glucagon pathways simultaneously, potentially offering enhanced benefits for women with PCOS who struggle with weight management and insulin resistance

We want to lose fat, we dont want to lose muscle, and we really dont want to lose bone